Upregulation of functionally active vascular endothelial growth factor by human cytomegalovirus

被引:20
作者
Reinhardt, B
Schaarschmidt, P
Bossert, A
Lüske, A
Finkenzeller, G
Mertens, T
Michel, D
机构
[1] Univ Ulm Klinikum, Abt Virol, D-89081 Ulm, Germany
[2] Roche Diagnost GmbH, D-82372 Penzberg, Germany
[3] Univ Hosp, Dept Plast Surg, D-79106 Freiburg, Germany
关键词
D O I
10.1099/vir.0.80327-0
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Human cytomegalovirus (HCMV) infection is known to modulate host gene expression and has been linked to the pathogenesis of vasculopathies; however, relevant pathomechanisms are still unclear. It was shown that HCMV infection leads to upregulation of vascular endothelial growth factor (VEGF) expression in human foreskin fibroblasts and coronary artery smooth muscle cells (SMC). Activation of VEGF transcription by HCMV infection was confirmed by transient-expression experiments, which revealed that a short promoter fragment, pLuc135 (-85 to + 50), is sufficient for activation. Site-directed mutagenesis of Sp1-recognition sites within this fragment abolished the upregulation of transcription. Functional VEGF protein is released into the culture supernatant of infected SMC. Incubation of endothelial cells with supernatants from HCMV-infected SMC cultures induced upregulation of VEGF receptor-2 expression on endothelial cells, as well as a significant upregulation of DNA synthesis, implicating cell proliferation. The mean incline of DNA synthesis at 48 and 72 h post-infection was 148 and 197%, respectively. Addition of neutralizing antibodies against VEGF completely abolished this effect. Supernatants from SMC cultures incubated with UV-inactivated virus induced a comparable effect. This virus-induced paracrine effect may represent a molecular mechanism for HCMV-induced pathogenesis, such as inflammatory vasculopathies, by inducing a proatherogenic phenotype in SMC.
引用
收藏
页码:23 / 30
页数:8
相关论文
共 32 条
[1]  
ALMEIDA GD, 1994, BLOOD, V83, P370
[2]   Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1 [J].
Barleon, B ;
Sozzani, S ;
Zhou, D ;
Weich, HA ;
Mantovani, A ;
Marme, D .
BLOOD, 1996, 87 (08) :3336-3343
[3]   Altered cellular mRNA levels in human cytomegalovirus-infected fibroblasts: Viral block to the accumulation of antiviral mRNAs [J].
Browne, EP ;
Wing, B ;
Coleman, D ;
Shenk, T .
JOURNAL OF VIROLOGY, 2001, 75 (24) :12319-12330
[4]   Vascular endothelial growth factor enhances atherosclerotic plaque progression [J].
Celletti, FL ;
Waugh, JM ;
Amabile, PG ;
Brendolan, A ;
Hilfiker, PR ;
Dake, MD .
NATURE MEDICINE, 2001, 7 (04) :425-429
[5]   Immunohistochemical expression of vascular endothelial growth factor vascular permeability factor in atherosclerotic intimas of human coronary arteries [J].
Chen, YX ;
Nakashima, Y ;
Tanaka, K ;
Shiraishi, S ;
Nakagawa, K ;
Sueishi, K .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (01) :131-139
[6]   VASCULAR-PERMEABILITY FACTOR - A TUMOR-DERIVED POLYPEPTIDE THAT INDUCES ENDOTHELIAL-CELL AND MONOCYTE PROCOAGULANT ACTIVITY, AND PROMOTES MONOCYTE MIGRATION [J].
CLAUSS, M ;
GERLACH, M ;
GERLACH, H ;
BRETT, J ;
WANG, F ;
FAMILLETTI, PC ;
PAN, YCE ;
OLANDER, JV ;
CONNOLLY, DT ;
STERN, D .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 172 (06) :1535-1545
[7]  
Couffinhal T, 1997, AM J PATHOL, V150, P1673
[8]   Leucocyte recruitment in rupture prone regions of lipid-rich plaques: a prominent role for neovascularization? [J].
de Boer, OJ ;
van der Wal, AC ;
Teeling, P ;
Becker, AE .
CARDIOVASCULAR RESEARCH, 1999, 41 (02) :443-449
[9]   Sp1 recognition sites in the proximal promoter of the human vascular endothelial growth factor gene are essential for platelet-derived growth factor-induced gene expression [J].
Finkenzeller, G ;
Sparacio, A ;
Technau, A ;
Marme, D ;
Siemeister, G .
ONCOGENE, 1997, 15 (06) :669-676
[10]  
HENDRIX MGR, 1991, AM J PATHOL, V138, P563